Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma convenes Extraordinary General Meeting on May 26, 2026
Company announcement – No. 12 / 2026 Zealand Pharma convenes Extraordinary General Meeting on May 26, 2026 Copenhagen, Denmark, May 1, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no.
Leo Pharma Is Said to Add More Banks to Copenhagen IPO Lineup
Leo Pharma AS has picked more banks to help it prepare for a possible initial public offering in Copenhagen, according to people familiar with the matter. The century-old drugmaker has brought in Goldman Sachs Group Inc., Jefferies Financial Group…
OxyContin maker Purdue Pharma's settlement, by the numbers
OxyContin maker Purdue Pharma is set to dissolve and be replaced with a new company operating in the public interest under the settlement of thousands of lawsuits that goes into effect Friday. It's among the largest in a series of settlements over…
Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026
Tokyo, Japan and Cambridge, UK, 1 May 2026 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the first quarter ended 31…
The Zealand Pharma Board of Directors proposes to elect Camilla Sylvest to the Board of Directors at an upcoming Extraordinary General Meeting
The Zealand Pharma Board of Directors proposes to elect Camilla Sylvest to the Board of Directors at an upcoming Extraordinary General Meeting Camilla Sylvest will bring deep commercial expertise to the Board at a critical stage, as Zealand Pharma…
Ex-Pharma Staff Booked For Fraudulent Government Tenders
Two former employees of a Delhi-based pharmaceutical firm have been booked for allegedly cheating and forging documents to fraudulently secure government tenders, including supplies to Army hospitals. Two former employees of a Delhi-based…
Review of pharma, medical devices sector's supply chain resilience on cards
India is undertaking an assessment of the industrial supply chain resilience and manufacturing capabilities of the pharmaceutical and medical devices sector. It is an important exercise and the Supply Chain Division of the Department of Commerce is…
Aurobindo Pharma arm CuraTeQ gets Health Canada NOC for Bevacizumab biosimilar
Aurobindo Pharma subsidiary CuraTeQ Biologics has received Notice of Compliance (NOC) from Health Canada's Biologics and Radiopharmaceutical Drugs Directorate (BRDD) for Bevqolva, its bevacizumab biosimilar. A humanised monoclonal antibody…
Curaleaf Completes Buyout of Remaining Stake in Germany's Four 20 Pharma
STAMFORD, Conn., April 30, 2026 /CNW/ -- Curaleaf Holdings, Inc (TSX: CURA) (OTCQX: CURLF) ('Curaleaf' or the 'Company'), a leading international provider of consumer products in cannabis, has completed the buyout of the remaining 45% stake not…
Lantern Pharma Inc. (LTRN) Discusses Live Demonstration of withZeta.ai Platform for AI-Driven Oncology Drug Discovery Transcript
Hello. This is Paul Kuntz with RedChip Companies. I want to thank everyone for joining us for what promises to be an exciting session with Lantern Pharma. Today's session is centered around a live real-time demonstration of withZeta.ai, Lantern…
Vanguard Group Inc. Increases Stake in BridgeBio Pharma, Inc. $BBIO
Vanguard Group Inc. grew its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 0.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 16,862,691 shares of the…
West Pharmaceutical: Multiple Growth Drivers Are A Tailwind (NYSE:WST)
West Pharmaceutical Services maintains dominant market share in injectable drug delivery, underpinned by a wide moat and robust regulatory positioning. WST reported strong Q1 2026 results, with revenue up 21% and adjusted EPS up 46.9%, prompting a…
Royalty Pharma (NASDAQ:RPRX) CFO Terrance Coyne Sells 34,791 Shares of Stock
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) CFO Terrance Coyne sold 34,791 shares of Royalty Pharma stock in a transaction dated Tuesday, April 28th. The stock was sold at an average price of $49.78, for a total value of $1,731,895.98. The…
Pictet Asset Management Holding SA Lowers Position in NewAmsterdam Pharma Company N.V. $NAMS
Pictet Asset Management Holding SA trimmed its holdings in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 42.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange…
Summit Therapeutics: It Still Feels Like The Market Got Ahead Of Itself (NASDAQ:SMMT)
Summit Therapeutics receives a reiterated Sell rating due to an over $17bn valuation unsupported by current fundamentals and competitive risks. Ivonescimab's FDA approval hinges on demonstrating statistically significant overall survival, which…
Receive a Daily briefing on Pharma Industry News
Get Started